Endoscopy 2019; 51(11): 1051-1058
DOI: 10.1055/a-0938-3918
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Cost-effectiveness of endoscopic ultrasound-directed transgastric ERCP compared with device-assisted and laparoscopic-assisted ERCP in patients with Roux-en-Y anatomy

Hailey J. James
1   Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States
,
Theodore W. James
2   Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, United States
,
Stephanie B. Wheeler
1   Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States
,
Jennifer C. Spencer
1   Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States
,
Todd H. Baron
2   Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, United States
› Author Affiliations
Further Information

Publication History

submitted 24 February 2019

accepted after revision 25 April 2019

Publication Date:
26 June 2019 (online)

Abstract

Background Roux-en-Y gastric bypass (RYGB) surgery is the second most common weight loss surgery in the United States. Treatment of pancreaticobiliary disease in this patient population is challenging due to the altered anatomy, which limits the use of standard instruments and techniques. Both nonoperative and operative modalities are available to overcome these limitations, including device-assisted (DAE) endoscopic retrograde cholangiopancreatography (ERCP), laparoscopic-assisted (LA) ERCP, and endoscopic ultrasound-directed transgastric ERCP (EDGE). The aim of this study was to compare the cost-effectiveness of ERCP-based modalities for treatment of pancreaticobiliary diseases in post-RYGB patients.

Methods A decision tree model with a 1-year time horizon was used to analyze the cost-effectiveness of EDGE, DAE-ERCP, and LA-ERCP in post-RYGB patients. Monte Carlo simulation was used to assess a plausible range of incremental cost-effectiveness ratios, net monetary benefit calculations, and a cost-effectiveness acceptability curve. One-way sensitivity analyses and probabilistic sensitivity analyses were also performed to assess how changes in key parameters affected model conclusions.

Results EDGE resulted in the lowest total costs and highest total quality-adjusted life-years (QALY) for a total of $5188/QALY, making it the dominant alternative compared with DAE-ERCP and LA-ERCP. In probabilistic analyses, EDGE was the most cost-effective modality compared with LA-ERCP and DAE-ERCP in 94.4 % and 97.1 % of simulations, respectively.

Conclusion EDGE was the most cost-effective modality in post-RYGB anatomy for treatment of pancreaticobiliary diseases compared with DAE-ERCP and LA-ERCP. Sensitivity analysis demonstrated that this conclusion was robust to changes in important model parameters.

Fig 1s – 5s, Table 1s, Table 2s

 
  • References

  • 1 Ponce J, DeMaria EJ, Nguyen NT. et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis 2016; 12: 1637-1639
  • 2 Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009; 19: 1605-1611
  • 3 Byrne TK. Complications of surgery for obesity. Surg Clin North America 2001; 81: 1181-1193
  • 4 Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg 1985; 149: 551-557
  • 5 Shiffman ML, Sugerman HJ, Kellum JM. et al. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991; 86: 1000-1005
  • 6 Nagem RG, Lazaro-da-Silva A, de Oliveira RM. et al. Gallstone-related complications after Roux-en-Y gastric bypass: a prospective study. Hepatobiliary Pancreat Dis Int 2012; 11: 630-635
  • 7 Skinner M, Popa D, Neumann H. et al. ERCP with the overtube-assisted enteroscopy technique: a systematic review. Endoscopy 2014; 46: 560-572
  • 8 Inamdar S, Slattery E, Sejpal DV. et al. Systematic review and meta-analysis of single-balloon enteroscopy-assisted ERCP in patients with surgically altered GI anatomy. Gastrointest Endosc 2015; 82: 9-19
  • 9 Kedia P, Sharaiha RZ, Kumta NA. et al. Internal EUS-directed transgastric ERCP (EDGE): game over. Gastroenterology 2014; 147: 566-568
  • 10 Tyberg A, Nieto J, Salgado S. et al. Endoscopic ultrasound (EUS)-directed transgastric endoscopic retrograde cholangiopancreatography or EUS: mid-term analysis of an emerging procedure. Clin Endosc 2017; 50: 185-190
  • 11 Kedia P, Kumta NA, Widmer J. et al. Endoscopic ultrasound-directed transgastric ERCP (EDGE) for Roux-en-Y anatomy: a novel technique. Endoscopy 2015; 47: 159-163
  • 12 Bukhari M, Kowalski T, Nieto J. et al. An international, multicenter, comparative trial of EUS-guided gastrogastrostomy-assisted ERCP versus enteroscopy-assisted ERCP in patients with Roux-en-Y gastric bypass anatomy. Gastrointest Endosc 2018; 88: 486-494
  • 13 Kedia P, Tarnasky PR, Nieto J. et al. EUS-directed transgastric ERCP (EDGE) versus laparoscopy-assisted ERCP (LA-ERCP) for Roux-en-Y gastric bypass (RYGB) anatomy: a multicenter early comparative experience of clinical outcomes. J Clin Gastroenterol 2019; 53: 304-308
  • 14 Kedia P, Kumta NA, Sharaiha R. et al. Bypassing the bypass: EUS-directed transgastric ERCP for Roux-en-Y anatomy. Gastrointest Endosc 2015; 81: 223-224
  • 15 Kedia P, Tyberg A, Kumta NA. et al. EUS-directed transgastric ERCP for Roux-en-Y gastric bypass anatomy: a minimally invasive approach. Gastrointest Endosc 2015; 82: 560-565
  • 16 Drummond M, Sculpher MJ, Torrance GW. et al. Methods for the economic evaluation of health care programmes. 3. Oxford: Oxford University Press; 2005
  • 17 Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness – the curious resilience of the $50,000-per-QALY threshold. New Engl J Med 2014; 371: 796-797
  • 18 Sanders GD, Neumann PJ, Basu A. et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-effectiveness in Health and Medicine. JAMA 2016; 316: 1093-1103
  • 19 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
  • 20 Banerjee N, Parepally M, Byrne TK. et al. Systematic review of transgastric ERCP in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis 2017; 13: 1236-1242
  • 21 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269
  • 22 Kedia P, Kumta NA, Widmer J. et al. Endoscopic ultrasound-directed transgastric ERCP (EDGE) for Roux-en-Y anatomy: a novel technique. Endoscopy 2015; 47: 159-163
  • 23 Vallabh H, Poushanchi B, Hsueh W. et al. EUS-directed transgastric ERCP (EDGE) with use of a 20-mm (10-mm lumen-apposing metal stent in a patient with Roux-en-Y gastric bypass. VideoGIE 2018; 3: 262-263
  • 24 Mendoza Ladd A. EUS-directed transgastric ERCP. VideoGIE 2018; 3: 175-176
  • 25 Xu MM, Carames C, Novikov A. et al. One-step endoscopic ultrasound directed gastro-gastrostomy ERCP (EDGE). Gastrointest Endosc 2017; 85: AB133
  • 26 Choi EK, Chiorean MV, Cote GA. et al. ERCP via gastrostomy vs. double balloon enteroscopy in patients with prior bariatric Roux-en-Y gastric bypass surgery. Surg Endosc 2013; 27: 2894-2899
  • 27 Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. HCUPnet. Available from: https://www.ahrq.gov/data/hcup/index.html
  • 28 Bureau of Labor Statistics. Consumer Price Index. Washington, DC: United States Department of Labor, Bureau of Labor Statistics; 2018 Available from: https://www.bls.gov/cpi/data.htm
  • 29 Bass EB, Pitt HA, Lillemoe KD. Cost-effectiveness of laparoscopic cholecystectomy versus open cholecystectomy. Am J Surg 1993; 165: 466-471
  • 30 Gregor JC, Ponich TP, Detsky AS. Should ERCP be routine after an episode of “idiopathic” pancreatitis? A cost-utility analysis. Gastrointest Endosc 1996; 44: 118-123
  • 31 Law R, Das A, Gregory D. et al. Endoscopic resection is cost-effective compared with laparoscopic resection in the management of complex colon polyps: an economic analysis. Gastrointest Endosc 2016; 83: 1248-1257
  • 32 Norum J, Vonen B, Olsen JA. et al. Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes’ B and C colorectal carcinoma. A cost-effectiveness analysis. Ann Oncol 1997; 8: 65-70
  • 33 Vergel YB, Chilcott J, Kaltenthaler E. et al. Economic evaluation of MR cholangiopancreatography compared to diagnostic ERCP for the investigation of biliary tree obstruction. Int J Surg 2006; 4: 12-19
  • 34 Centers for Medicare & Medicaid Services. Physician Fee Schedule Search. Baltimore, MD: CMS.gov; 2017 Available from: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/MLN-Publications-Items/CMS1243670.html